3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Urinary Bladder Neoplasms
3
Neoplasm Metastasis
2
Thymoma
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Skin Neoplasms
1
Prostatic Neoplasms
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Muscle Invasive Bladder Urothelial Carcinoma
1
Melanoma
1
Lymphatic Metastasis
1
Head and Neck Neoplasms
1
Diabetes Mellitus, Insulin-Dependent, 10
1
Carcinoma, Transitional Cell
1
Carcinoma, Squamous Cell
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Merkel Cell
1
Interventions
fludarabine
2
Cyclophosphamide
2
Carboplatin
2
pembrolizumab
1
fludarabine phosphate
1
decitabine and cedazuridine drug combination
1
Radiotherapy, Intensity-Modulated
1
Platinum
1
Pemetrexed
1
Nivolumab
1
Ipilimumab
1
Fluorodeoxyglucose F18
1
Cisplatin
1
Cerebral Decortication
1
Blood Component Removal
1
Bevacizumab
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Mesothelioma
×
avelumab
×
30 days
×
Clear all
No trials found.